SEATTLE — Feb. 3, 2020 — Fred Hutchinson Cancer Research Center will host a press breakfast at the annual meeting of the American Association for the Advancement of Science, to be held Feb. 13-16 in Seattle.
At the Feb. 14 breakfast, Dr. Thomas J. Lynch Jr., the new president and director of Fred Hutch, will moderate a panel of Hutch experts on the topic “Future of Medicine: Body, Heal Thyself.” There will also be Q&A with the audience.
Thousands of scientists, educators, policymakers, journalists and others are expected to attend the AAAS annual meeting. AAAS is the world’s largest multi-disciplinary science society.
What: Press breakfast, “Future of Medicine: Body, Heal Thyself”
When: Friday, Feb. 14, 7:45 — 8:45 a.m. PT
Where: Washington State Convention Center, Level 2, Room 2AB
Dr. Thomas J. Lynch Jr., president and director, Fred Hutch
Dr. Jennifer Adair, assistant member of Fred Hutch’s Clinical Research Division, and Fleischauer Family Endowed Chair in Gene Therapy Translation
Dr. Raphael Gottardo, scientific director of the Translational Data Science Integrated Research Center, member of Fred Hutch’s Vaccine and Infectious Disease Division, J. Orin Edson Foundation Endowed Chair
Dr. Veena Shankaran, co-director of the Hutchinson Institute for Cancer Outcomes Research (HICOR), associate member of Fred Hutch’s Public Health Sciences Division, and a physician at Seattle Cancer Care Alliance, the Hutch’s clinical-care partner
Description: Does the future of medicine hinge on rigging the body to cure itself? Find out how Fred Hutch scientists are reengineering cells to fight HIV, cancer and other diseases. The team that harnessed the immune system to cure previously uncurable cancers will give the latest on new technology, approaches and scientific understanding that are allowing medical advances that were inconceivable just five years ago. You’ll walk away understanding how technology is helping us harness the immune system to revolutionize how diseases are treated, and what everyone needs to know about how to best make next-generation cures accessible to all.
# # #